NCT04825756

Brief Summary

The purpose of this pilot study is to evaluate the impact of Reining in Anxiety for children with anxiety and their caregivers. A total of up to 80 child/caregiver dyads will be enrolled in the study, anticipating that 40 dyads will complete the 10 week intervention. The intervention will be delivered at Fieldstone Farm Therapeutic Riding Center, which is one of the largest therapeutic riding centers in the US.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 22, 2021

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

March 23, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

February 10, 2022

Status Verified

February 1, 2022

Enrollment Period

6 months

First QC Date

March 23, 2021

Last Update Submit

February 8, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in levels of Anxiety

    This will be measured by the Generalized Anxiety Disorder-2 (GAD-2) questionnaire which consists of two items that assesses the presence of anxiety. Items are summed, and a score of 3 or higher is usually indicative of further evaluation.

    Before Session 1 (baseline) , After Session 10 ( after 6 months)

  • Change in the Psychological functioning

    The Children's Global Assessment Scale (CGAS). The child is given a single score between 1- 100, based on an assessment of a range of aspects related to the child's psychological and social functioning. The score places them in one of ten categories, ranging from "extremely impaired" (1-10) to "doing very well (91-100).

    Before Session 1 (baseline) , After Session 10 ( after 6 months)

Secondary Outcomes (8)

  • Change in children's emotional regulation

    Before Session 1 (baseline) , After Session 10 ( after 6 months)

  • Change in parents' perception of children's emotional regulation

    Before Session 1 (baseline) , After Session 10 ( after 6 months)

  • Change in emotional self efficacy

    Before Session 1 (baseline) , After Session 10 ( after 6 months)

  • Change in the level of knowledge of anxiety

    Before Session 1 (baseline) , After Session 10 ( after 6 months)

  • Traumatic events of children

    Before Session 1 (baseline)

  • +3 more secondary outcomes

Study Arms (1)

Treatment Group

EXPERIMENTAL

A total of up to 80 child/caregiver dyads will be enrolled in the study, anticipating that 40 dyads will complete the 10 week intervention. An equine assisted therapy called Reining in Anxiety for children with anxiety and their caregivers.

Behavioral: Manualized equine assisted therapy

Interventions

This equine assisted therapy (EAT), which is delivered in a group setting, combines therapeutic horseback riding with cognitive behavioral strategies for anxiety. Each 45 minute session is delivered in a group format with up to four children between 6 and 17 years of age. Each session follows the same structure: (1) weekly review; (2) groom and connect; (3) warm-up period; (4) session activity; (5) cool down; (6) parent/caregiver psychoeducation, during which the instructor facilitates psychoeducation; and (7) homework instruction.

Treatment Group

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Caregiver/child dyads where the children are between six and 17 years of age and their caregivers will be enrolled in the study.
  • Children must have a score of 3 or higher as measured by the GAD-2,
  • Children must have a minimum level of functioning as measured by the CGAS of 41 or higher.

You may not qualify if:

  • An inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Kimberly Hoagwood, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2021

First Posted

April 1, 2021

Study Start

February 22, 2021

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

February 10, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Pilot study data only

Locations